Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel biomarkers in bladder cancer.

Urologic oncology - 1 Mar 2018

Cheng Michael L, Iyer Gopa

Abstract excerpt

A sea change has occurred in the treatment options available for metastatic urothelial bladder cancer with the recent Food and Drug Administration approval of 5 immune checkpoint blockade agents for patients who have progressed on platinum-based chemotherapy or are not candidates for cisplatin. Additionally, comprehensive characterization of the landscape of genomic alterations in this disease through The Cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Carcinoma, Transitional Cell
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antineoplastic Agents, Immunological

Share to Molecular Targeted Therapy

Share to Precision Medicine

Share to Programmed Cell Death 1 Receptor

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 29472156
DOI: 10.1016/j.urolonc.2018.01.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel biomarkers in bladder cancer.PMID 29472156Read ↗

Molecular markers in bladder cancerSemantic proximity Read ↗

The Cancer Genome Atlas Project in Bladder Cancer.Semantic proximity Read ↗

New discoveries in the molecular landscape of bladder cancerSemantic proximity Read ↗

New and promising strategies in the management of bladder cancer.Semantic proximity Read ↗

Bladder Cancer in the Genomic EraSemantic proximity Read ↗

Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and SurveillanceSemantic proximity Read ↗

Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy.Semantic proximity Read ↗

Molecular pathogenesis of urothelial carcinoma: the clinical utility of emerging new biomarkers and future molecular classification of bladder cancer.Semantic proximity Read ↗

Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?Semantic proximity Read ↗

Advances in bladder cancer biology and therapy.Semantic proximity Read ↗

A Candidate Molecular Biomarker Panel for the Detection of Bladder CancerSemantic proximity Read ↗

Molecular biomarkers in urothelial bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.